---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-023096"
form_type: "8-K"
ticker: "IBO"
cik: "0001834105"
company_name: "IMPACT BIOMEDICAL INC."
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:41:00.072498+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Heng Fai Ambrose Chan resigns; Jason T. Grady appointed to board

## Summary
- Heng Fai Ambrose Chan resigned as director effective June 6, 2024, with no disagreement.
- Board appointed Jason T. Grady as director effective June 6, 2024.
- Grady is COO of DSS, Inc., President of Premier Packaging, President/COO of DSS Wealth Management and BioLife Science.
- No arrangement or understanding regarding Grady's appointment; no family relationship or related party transaction.

## SEC filing metadata
- accession: 0001493152-24-023096
- form_type: 8-K
- ticker: IBO
- cik: 0001834105
- company_name: IMPACT BIOMEDICAL INC.
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1834105/000149315224023096/0001493152-24-023096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1834105/000149315224023096/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-023096
- JSON: https://secwatch.observer/filing/0001493152-24-023096.json
- Plain text: https://secwatch.observer/filing/0001493152-24-023096.txt

## Key facts
- Executive change
  Jason T. Grady was appointed as Director at IMPACT BIOMEDICAL INC..
  - Action: appointed
  - Role: Director
  source text: Additionally on June 6, 2024, the Board of Directors of the Company appointed Jason T. Grady to serve as a Director of the Company, effective as of the same date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1834105/000149315224023096/0001493152-24-023096-index.htm
- Executive change
  Heng Fai Ambrose Chan resigned as Director at IMPACT BIOMEDICAL INC..
  - Action: resigned
  - Role: Director
  source text: On June 6, 2024, Heng Fai Ambrose Chan notified Impact Biomedical, Inc. (the “Company”) that he is resigning as a member of the Board of Directors of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1834105/000149315224023096/0001493152-24-023096-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.